Cargando…
Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artif...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975557/ https://www.ncbi.nlm.nih.gov/pubmed/35369433 http://dx.doi.org/10.3389/fmicb.2022.854690 |
_version_ | 1784680389434933248 |
---|---|
author | Riedl, André Fischer, Julian Burgert, Hans-Gerhard Ruzsics, Zsolt |
author_facet | Riedl, André Fischer, Julian Burgert, Hans-Gerhard Ruzsics, Zsolt |
author_sort | Riedl, André |
collection | PubMed |
description | Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artificial chromosomes. Although the rescue of rAds from their circular plasmid or bacmid forms is well established, it works with relatively low primary efficiency, preventing this technology for library applications. To overcome this barrier, we tested a novel strategy for the reconstitution of rAds that utilizes the CRISPR/Cas-machinery to cleave the circular rAd genomes in close proximity to their inverted terminal repeats (ITRs) within the producer cells upon transfection. This CRISPR/Cas-mediated in vivo terminal resolution allowed efficient rescue of vectors derived from different human adenovirus (HAdV) species. By this means, it was not only possible to increase the efficiency of virus rescue by about 50-fold, but the presented methodology appeared also remarkably simpler and faster than traditional rAd reconstitution methods. |
format | Online Article Text |
id | pubmed-8975557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89755572022-04-02 Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution Riedl, André Fischer, Julian Burgert, Hans-Gerhard Ruzsics, Zsolt Front Microbiol Microbiology Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artificial chromosomes. Although the rescue of rAds from their circular plasmid or bacmid forms is well established, it works with relatively low primary efficiency, preventing this technology for library applications. To overcome this barrier, we tested a novel strategy for the reconstitution of rAds that utilizes the CRISPR/Cas-machinery to cleave the circular rAd genomes in close proximity to their inverted terminal repeats (ITRs) within the producer cells upon transfection. This CRISPR/Cas-mediated in vivo terminal resolution allowed efficient rescue of vectors derived from different human adenovirus (HAdV) species. By this means, it was not only possible to increase the efficiency of virus rescue by about 50-fold, but the presented methodology appeared also remarkably simpler and faster than traditional rAd reconstitution methods. Frontiers Media S.A. 2022-03-18 /pmc/articles/PMC8975557/ /pubmed/35369433 http://dx.doi.org/10.3389/fmicb.2022.854690 Text en Copyright © 2022 Riedl, Fischer, Burgert and Ruzsics. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Riedl, André Fischer, Julian Burgert, Hans-Gerhard Ruzsics, Zsolt Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title | Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title_full | Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title_fullStr | Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title_full_unstemmed | Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title_short | Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution |
title_sort | rescue of recombinant adenoviruses by crispr/cas-mediated in vivo terminal resolution |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975557/ https://www.ncbi.nlm.nih.gov/pubmed/35369433 http://dx.doi.org/10.3389/fmicb.2022.854690 |
work_keys_str_mv | AT riedlandre rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution AT fischerjulian rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution AT burgerthansgerhard rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution AT ruzsicszsolt rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution |